Podcast

Ron Wince, president and CEO of Guidon Performance Solutions, Discusses Healthcare Reform

HCPLive interviewed Ron Wince, president and CEO of Guidon Performance Solutions about the healthcare reform bill.

HCPLive interviewed Ron Wince, president and CEO of Guidon Performance Solutions a management consulting firm that works with healthcare organizations to improve operational efficiency, about the healthcare reform bill. He shared his opinions on tort reform, the bill's impact on physicians and patients, government process, and how the bill impacts healthcare IT companies.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Related Content
PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering
November 28th 2024

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

Victoria Johnson
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
Zahi Touma, MD, PhD, director, Toronto Lupus Program and Associate Professor of medicine, department of medicine, division of rheumatology, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
November 27th 2024

Anifrolumab Delayed Onset of Organ Damage in Patients With SLE

Victoria Johnson
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Study Shows Many with Treatment-Resistant Schizophrenia Have a Poor Diet
November 26th 2024

Study Shows Many with Treatment-Resistant Schizophrenia Have a Poor Diet

Chelsie Derman
FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM | Image Credit: US Food and Drug Administration
November 26th 2024

FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.